Results 191 to 200 of about 138,386 (251)

Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targets. [PDF]

Acta Neuropathol Commun
Brunet A, Coulpier F, Onfroy A, Sako N, Radomska KJ, Aftimos V, Lacroix L, Briand-Suleau A, Maille P, Hermeziu O, Laurendeau I, Pasmant E, Wolkenstein P, Topilko P, Ortonne N.   +14 more
europepmc   +1 more source

Clonal expansion and phenotypic alterations of TCR Vβ3⁺ T cells in juvenile-onset recurrent respiratory papillomatosis: implications for tumor-associated immunity and chemokine-mediated T-cell trafficking. [PDF]

J Virol
Li S, Wang W, Peng Y, Wang G, Xi Y, Wang S, Zhao J, Zhang F, Wang H, Li H, Duan Q, Long T, Gui J, Ni X, Zhang J.   +14 more
europepmc   +1 more source

Correlation between intestinal flora characteristics and immune function in COPD patients treated with non-invasive ventilator and its value in predicting ventilator-associated pneumonia: A prospective study. [PDF]

Medicine (Baltimore)
Liu Y, Liu C, Huang C, Pang L.
europepmc   +1 more source

A Deep‐Red‐Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death

Angewandte Chemie, EarlyView.
A deep‐red‐excited osmium(II) photosensitizer (Os2) induces immunogenic cell death (ICD) under 740 nm irradiation and triggers robust anti‐tumor immune responses both in vitro and in vivo. ABSTRACT Immunogenic cell death (ICD), which converts tumor cells into their own vaccine, plays a pivotal role in the development of novel anticancer therapies. Here,
Yiyi Zhang, Pierre Mesdom, Eduardo Izquierdo‐García, João P. M. António, Ruonan Gao, Bruno Saubaméa, Johanne Seguin, Morgane Moinard, Philippe Arnoux, Céline Frochot, Kevin Cariou, Bich‐Thuy Doan, Gilles Gasser   +12 more
wiley   +1 more source

Immunological Profiling of Leukocyte Subset Proportions and Novel Blood Biomarkers in the Acute Phase of Ocular Sarcoidosis and Vogt-Koyanagi-Harada Disease: An Exploratory Pilot Study. [PDF]

Int J Mol Sci
Sato T, Takenaka Y, Nishio Y, Ito M, Takeuchi M.   +4 more
europepmc   +1 more source

Outcomes of PTCY-Based Haploidentical Transplants and Donor Factors Affecting Outcomes: A 12-year Experience from India. [PDF]

Blood Cell Ther
Jindal N, Gokarn A, Garg M, Kumbhalwar K, D Silva S, Singh M, Kannan S, Jacob Mathew L, Mirgh S, Chichra A, Nayak L, Bonda A, Punatar S, Bagal B, Khattry N.   +14 more
europepmc   +1 more source

A Novel Pathogenic Variant in TRAC Gene Associated with SCID Phenotype: Expanding the Genetic and Clinical Spectrum. [PDF]

J Clin Immunol
Karaselek MA, Ozbey MY, Uygun V, Kuccukturk S, Karabey N, Tokdemir U, Ozel G, Demircioglu ZD, Yildirim S, Sahin A, Duran T, Akkus A, Yildirim S, Guner S, Reisli İ, Keles S.   +15 more
europepmc   +1 more source

Engineering of acidic pH-responsive anti-CD3 binding antibodies. [PDF]

MAbs
La Sala G, Kroell KB, Pincha M, Gassner C, Deho L, Moessner E, Gueripel X, Borin N, Classen M, Benz J, Bujotzek A, Klein C, Georges G, Hugenmatter A, Liedl KR, Vangone A.   +15 more
europepmc   +1 more source

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA. [PDF]

Exp Hematol Oncol
Campillo-Davo D, Flumens D, Berneman ZN, Fujiki F, Roex G, Versteven M, Van Acker HH, Van Tendeloo VFI, Sugiyama H, Anguille S, Lion E.   +10 more
europepmc   +1 more source